● British start-up Clerkenwell Health, Europe’s first commercial psychedelic clinical trials facility, and brain wellness and analytics company MYndspan, are partnering to advance the application of psychedelics in medicine ● Psychedelics researchers running trials at Clerkenwell Health’s new London site will have access to MYndspan’s non-invasive brain scanning technology ● This first-of-its-kind…
Source